Abstract:RationaleTh2 cells play critical roles in the pathogenesis of allergic asthma. Established Th2 cells have been shown to resist reprogramming toward Th1 cells. We sought to understand the mechanisms by which asthmatic CD4+ T cells develop resistance to IL-27-mediated inhibition of Th2 differentiation.MethodsWe isolated and cultured CD4+ T cells from healthy individuals and allergic asthmatic patients and tested whether IL-27 can inhibit IL-4 production by the cultured CD4+ T cells using ELISA. STAT1 phosphorylation was analyzed by Western blot and flow cytometry. Suppressor of cytokine signaling (SOCS) mRNA expressions were measured by qPCR. The siRNA method was used to knockdown SOCS3 mRNA expression.ResultsWe demonstrate that CD4+ T cells from asthmatic patients resisted human IL-27-mediated suppression of IL-4 production. We observed that repeated exposures to Th2-inducing conditions rendered healthy human CD4+ T cells resistant to IL-27-mediated inhibition. Using an in vitro murine culture system, we further demonstrated that repeated or higher doses of IL-4, but not IL-2, stimulation upregulated SOCS3 mRNA expression and impaired IL-27-induced STAT1 phosphorylation. Py-STAT1 expression was impaired in Th2 memory cells circulating in peripheral blood isolated in asthmatics, but not in normal subjects. Knockdown of SOCS3 expression restored IL-27-mediated inhibition.ConclusionsOur findings demonstrate that differentiated Th2 cells can resist IL27-induced reprogramming toward Th1 cells by downregulating STAT1 phosphorylation and upregulation of SOCS3 and may explain why asthmatic CD4+ T cells are resistant to IL-27- mediated differential inhibition. RationaleTh2 cells play critical roles in the pathogenesis of allergic asthma. Established Th2 cells have been shown to resist reprogramming toward Th1 cells. We sought to understand the mechanisms by which asthmatic CD4+ T cells develop resistance to IL-27-mediated inhibition of Th2 differentiation. Th2 cells play critical roles in the pathogenesis of allergic asthma. Established Th2 cells have been shown to resist reprogramming toward Th1 cells. We sought to understand the mechanisms by which asthmatic CD4+ T cells develop resistance to IL-27-mediated inhibition of Th2 differentiation. MethodsWe isolated and cultured CD4+ T cells from healthy individuals and allergic asthmatic patients and tested whether IL-27 can inhibit IL-4 production by the cultured CD4+ T cells using ELISA. STAT1 phosphorylation was analyzed by Western blot and flow cytometry. Suppressor of cytokine signaling (SOCS) mRNA expressions were measured by qPCR. The siRNA method was used to knockdown SOCS3 mRNA expression. We isolated and cultured CD4+ T cells from healthy individuals and allergic asthmatic patients and tested whether IL-27 can inhibit IL-4 production by the cultured CD4+ T cells using ELISA. STAT1 phosphorylation was analyzed by Western blot and flow cytometry. Suppressor of cytokine signaling (SOCS) mRNA expressions were measured by qPCR. The siRNA method was used to knockdown SOCS3 mRNA expression. ResultsWe demonstrate that CD4+ T cells from asthmatic patients resisted human IL-27-mediated suppression of IL-4 production. We observed that repeated exposures to Th2-inducing conditions rendered healthy human CD4+ T cells resistant to IL-27-mediated inhibition. Using an in vitro murine culture system, we further demonstrated that repeated or higher doses of IL-4, but not IL-2, stimulation upregulated SOCS3 mRNA expression and impaired IL-27-induced STAT1 phosphorylation. Py-STAT1 expression was impaired in Th2 memory cells circulating in peripheral blood isolated in asthmatics, but not in normal subjects. Knockdown of SOCS3 expression restored IL-27-mediated inhibition. We demonstrate that CD4+ T cells from asthmatic patients resisted human IL-27-mediated suppression of IL-4 production. We observed that repeated exposures to Th2-inducing conditions rendered healthy human CD4+ T cells resistant to IL-27-mediated inhibition. Using an in vitro murine culture system, we further demonstrated that repeated or higher doses of IL-4, but not IL-2, stimulation upregulated SOCS3 mRNA expression and impaired IL-27-induced STAT1 phosphorylation. Py-STAT1 expression was impaired in Th2 memory cells circulating in peripheral blood isolated in asthmatics, but not in normal subjects. Knockdown of SOCS3 expression restored IL-27-mediated inhibition. ConclusionsOur findings demonstrate that differentiated Th2 cells can resist IL27-induced reprogramming toward Th1 cells by downregulating STAT1 phosphorylation and upregulation of SOCS3 and may explain why asthmatic CD4+ T cells are resistant to IL-27- mediated differential inhibition. Our findings demonstrate that differentiated Th2 cells can resist IL27-induced reprogramming toward Th1 cells by downregulating STAT1 phosphorylation and upregulation of SOCS3 and may explain why asthmatic CD4+ T cells are resistant to IL-27- mediated differential inhibition.

Abnormal suppressive capacity of regulatory T cells to Th17 and Th9 cells in asthmatic patients

Effect of T-regulatory cells on helper T1 and helper T2 cells in asthmatic patients

The Imbalance of FOXP3/GATA3 in Regulatory T Cells from the Peripheral Blood of Asthmatic Patients

An increased ratio of Th2/Treg cells in patients with moderate to severe asthma.

Regulatory T Cells and Th1/Th2 in Peripheral Blood and Their Roles in Asthmatic Children.

Coexistence of Th1/Th2 and Th17/Treg Imbalances in Patients with Allergic Asthma.

The Changes of Regulatory T Cells and T Helper Cell in Peripheral Blood and Their Significance in Patients with Asthma

Expression of interleukin-17~+ regulatory T cells in peripheral blood of allergic asthma and its clinical significance

Reduced CCR6+IL-17A+Treg Cells in Blood and CCR6-Dependent Accumulation of IL-17A+Treg Cells in Lungs of Patients With Allergic Asthma

Induction Of Cd4(+)Cd25(+)Foxp3(+)Il-10(+) T Cells In Hdm-Allergic Asthmatic Children With Or Without Sit

The Declined CD4+ CD25+Treg Cells in Patients with Moderate to Severe Asthma Associated with Over-Expressed Th2 Response

Expression of GATA3 and PIM2 of Regulatory T Cells in Peripheral Blood of Patients with Asthma and Clinical Significance

Th17 Immunity In Patients With Allergic Asthma

Analysis of CD4 + CD25 + regulatory T cells and Foxp3 mRNA in the peripheral blood of patients with asthma

CD4+ CD25+ regulatory T cells and expressions of forkhead/winged helix transcription factor ( Foxp 3 ) mRNA in peripheral blood of patients with asthma

The roles of thymic stromal lymphopoietin receptor and its antibody in airway inflammatory response in asthmatic mice

Insufficient Increment of Cd4+Cd25+Regulatory T Cells after Stimulation in Vitro with Allergen in Allergic Asthma

Recent Advance in Regulatory T Cells and Bronchial Asthma

CD4+CD25+FOXP3+ Regulatory T cells in Asthmatic Mice

Role of Regulatory T Cells with IL-4R Expression in Allergic Asthma

Impairment of IL-27's Differential Effect on CD4+T Cells in Asthma